I would be happy right now with 5000% gain = approximately $10. But, is it worth more if it shows to be a Covid-19 killer in human trials like I think. The market will tell us. We are not going to have to wait much longer for this to play out and we will have the answers.
DeGrado comeback to Brilacidin for a reason. I suspect that its self is a huge tell.
November 2, 2020 INNOVATION PHARMACEUTICALS RECEIVES PRE-IND RESPONSE FROM FDA ON COVID-19 TRIAL
October 30, 2020 INNOVATION PHARMACEUTICALS AND GEORGE MASON UNIVERSITY ANNOUNCE PUBLIC RELEASE OF LABORATORY TESTING RESULTS DEMONSTRATING BRILACIDIN’S COVID-19 TREATMENT POTENTIAL
October 2, 2020 INNOVATION PHARMACEUTICALS ANNOUNCES PRE-IND MEETING REQUEST GRANTED BY FDA FOR THE STUDY OF BRILACIDIN FOR THE TREATMENT OF COVID-19
September 15, 2020 LABORATORY TESTING OF BRILACIDIN FOR COVID-19 IN COMBINATION WITH REMDESIVIR REDUCES VIRAL LOAD BY NEARLY 100 PERCENT
September 8, 2020 INNOVATION PHARMACEUTICALS ANNOUNCES PUBLICATION OF INDEPENDENT RESEARCH ON KEVETRIN, THE COMPANY’S P53 DRUG CANDIDATE, IN ONCOLOGY REPORTS
August 26, 2020 DR. WILLIAM F. DEGRADO, A DISCOVERER OF BRILACIDIN, JOINS INNOVATION PHARMACEUTICALS AS SCIENTIFIC ADVISOR
If the human trials show even half of what the lab results were, and that information isn’t censored, then IPIX will be off the charts value wise, at least initially. Eventually it will be priced properly. I have no idea what it will be but certainly a 5000% gain is not out of the park. For starters.